|
Volumn 36, Issue 6, 2001, Pages 641-643
|
Position paper: Bisphosphonates as antialveolar macrophage therapy in pulmonary Langerhans cell histiocytosis?
|
Author keywords
Alveolar macrophages; Bisphosphonates; Langerhans cell histiocytosis
|
Indexed keywords
ARTIFICIAL LUNG SURFACTANT;
BISPHOSPHONIC ACID DERIVATIVE;
CATHEPSIN D;
CD1 ANTIGEN;
CD68 ANTIGEN;
CLODRONIC ACID;
DIPEPTIDYL CARBOXYPEPTIDASE;
GADOLINIUM CHLORIDE;
GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;
INTERLEUKIN 4;
OMEGA 3 FATTY ACID;
TRANSFORMING GROWTH FACTOR BETA1;
TUMOR NECROSIS FACTOR ALPHA;
TYLOXAPOL;
CATHEPSIN;
CD68 ANTIGEN, HUMAN;
DIFFERENTIATION ANTIGEN;
LEUKOCYTE ANTIGEN;
CIGARETTE SMOKING;
CLINICAL FEATURE;
DRUG MECHANISM;
HISTIOCYTE;
HISTIOCYTOSIS X;
HISTOGENESIS;
LANGERHANS CELL;
LUNG ALVEOLUS MACROPHAGE;
NONHUMAN;
PATHOGENESIS;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
SHORT SURVEY;
ARTICLE;
DRUG EFFECT;
HUMAN;
LUNG;
METABOLISM;
ANTIGENS, CD;
ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC;
CATHEPSINS;
DIPHOSPHONATES;
HISTIOCYTOSIS, LANGERHANS-CELL;
HUMANS;
LUNG;
MACROPHAGES, ALVEOLAR;
PEPTIDYL-DIPEPTIDASE A;
|
EID: 0035036929
PISSN: 00981532
EISSN: None
Source Type: Journal
DOI: 10.1002/mpo.1142 Document Type: Short Survey |
Times cited : (17)
|
References (22)
|